TCL Archive DCE Board Approves Two New Grant Programs, New Contract, Recompetitions Totaling $22 Mil. March 9, 1990
TCL Archive NCI Natural Product Drug Development To Get New Emphasis; Suggestions Of Critic Accepted March 19, 1976
TCL Archive NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner. June 2, 2006
TCL Archive Funding Exceptions, Skipovers, While Limited At NCI, Become Crucial Issues; NCAB To Be Brief On Details January 7, 1983